KRAS and KIT Gatekeeper Mutations Confer Polyclonal Primary Imatinib Resistance in GI Stromal Tumors: Relevance of Concomitant Phosphatidylinositol 3-Kinase/AKT Dysregulation

Gardado en:
Detalles Bibliográficos
Publicado en:J Clin Oncol
Main Authors: Serrano, César, Wang, Yuexiang, Mariño-Enríquez, Adrián, Lee, Jen-Chieh, Ravegnini, Gloria, Morgan, Jeffrey A., Bertagnolli, Monica M., Beadling, Carol, Demetri, George D., Corless, Christopher L., Heinrich, Michael C., Fletcher, Jonathan A.
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Clinical Oncology 2015
Assuntos:
Diagnosis in Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC4559610/
https://ncbi.nlm.nih.gov/pubmed/24687822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2013.48.7488
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares